Holen Sie sich die Stockscreener-App
18.69
1.53%
-0.29
Vorhandelsmarkt:
18.42
-0.27
-1.44%
Schlusskurs vom Vortag:
$18.98
Offen:
$18.66
24-Stunden-Volumen:
21.52M
Relative Volume:
0.88
Marktkapitalisierung:
$9.99B
Einnahmen:
$1.41B
Nettoeinkommen (Verlust:
$-91.57M
KGV:
-116.81
EPS:
-0.16
Netto-Cashflow:
$308.77M
1W Leistung:
+25.77%
1M Leistung:
+31.62%
6M Leistung:
+41.38%
1J Leistung:
+27.06%
1-Tages-Spanne:
$18.23
$18.95
1-Wochen-Bereich:
$15.75
$19.84
52-Wochen-Spanne:
$9.38
$19.84
Uipath Inc Stock (PATH) Company Profile
Firmenname
Uipath Inc
Sektor
Branche
Telefon
(844) 432-0455
Adresse
ONE VANDERBILT AVENUE, NEW YORK
Vergleichen Sie PATH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PATH
Uipath Inc
|
18.69 | 10.15B | 1.41B | -91.57M | 308.77M | -0.16 |
|
MSFT
Microsoft Corporation
|
478.56 | 3.66T | 293.81B | 104.91B | 78.02B | 14.06 |
|
ORCL
Oracle Corp
|
223.01 | 631.54B | 59.02B | 12.63B | -5.88B | 4.3198 |
|
PLTR
Palantir Technologies Inc
|
187.91 | 433.40B | 3.90B | 1.10B | 1.79B | 0.4275 |
|
CRWD
Crowdstrike Holdings Inc
|
519.54 | 130.58B | 4.57B | -315.36M | 1.10B | -1.2634 |
|
SNPS
Synopsys Inc
|
475.83 | 88.78B | 6.43B | 1.15B | 1.30B | 12.77 |
Uipath Inc Stock (PATH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-02 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-09-05 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-09-05 | Fortgesetzt | DA Davidson | Neutral |
| 2025-03-13 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-12 | Eingeleitet | UBS | Sell |
| 2024-06-03 | Herabstufung | Macquarie | Outperform → Neutral |
| 2024-05-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-05-30 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-05-30 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-30 | Herabstufung | Truist | Buy → Hold |
| 2024-05-30 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-04-08 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-03-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-03-14 | Bestätigt | Needham | Buy |
| 2024-02-21 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-01-02 | Eingeleitet | William Blair | Outperform |
| 2023-06-09 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-04-21 | Eingeleitet | DA Davidson | Neutral |
| 2023-03-16 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-11-03 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-10-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-09-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-07 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-01-25 | Hochstufung | Macquarie | Neutral → Outperform |
| 2022-01-20 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-09 | Hochstufung | Berenberg | Hold → Buy |
| 2021-12-03 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-09-17 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-07-12 | Eingeleitet | Summit Insights | Sell |
| 2021-05-17 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-05-17 | Eingeleitet | Barclays | Equal Weight |
| 2021-05-17 | Eingeleitet | BofA Securities | Buy |
| 2021-05-17 | Eingeleitet | Canaccord Genuity | Hold |
| 2021-05-17 | Eingeleitet | Cowen | Outperform |
| 2021-05-17 | Eingeleitet | DA Davidson | Buy |
| 2021-05-17 | Eingeleitet | Evercore ISI | In-line |
| 2021-05-17 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-17 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2021-05-17 | Eingeleitet | Macquarie | Neutral |
| 2021-05-17 | Eingeleitet | Mizuho | Buy |
| 2021-05-17 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-05-17 | Eingeleitet | Needham | Buy |
| 2021-05-17 | Eingeleitet | Oppenheimer | Perform |
| 2021-05-17 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-05-17 | Eingeleitet | Truist | Buy |
| 2021-05-17 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-05-17 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-05-13 | Eingeleitet | Berenberg | Hold |
Alle ansehen
Uipath Inc Aktie (PATH) Neueste Nachrichten
UiPath (NYSE:PATH) Shares Down 1.6% Following Insider Selling - MarketBeat
Insider Selling: UiPath (NYSE:PATH) CEO Sells 45,000 Shares of Stock - MarketBeat
Uipath Insider Sold Shares Worth $837,482, According to a Recent SEC Filing - marketscreener.com
UiPath Integrates with Talkdesk to Streamline Customer Experience - CMSWire
UiPath Business Trends Stabilizing as Automation Demand Grows, RBC Says - marketscreener.com
UiPath and Talkdesk join forces to transform customer experience journeys - Directors Club News -
RBC Capital raises UiPath stock price target to $19 on stabilizing trends - Investing.com India
UiPath (NYSE:PATH) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says - MarketBeat
UiPath, Inc. $PATH Shares Sold by Sirios Capital Management L P - MarketBeat
RBC Raises Price Target on UiPath to $19 From $16, Keeps Sector Perform Rating - marketscreener.com
UiPath price stallsForecast today10-12-2025 - Economies.com
Amundi Grows Stock Position in UiPath, Inc. $PATH - MarketBeat
AGS Health(R) Earns Consecutive UiPath AI25 Award for Breakthroughs in Healthcare Denial Management - Livingston Daily
5 Revealing Analyst Questions From UiPath’s Q3 Earnings Call - Markets Financial Content
UiPath surges on earnings: Should investors chase the momentum? - MSN
UiPath (NYSE:PATH) Shares Down 1.7% After Insider Selling - MarketBeat
Uipath Insider Sold Shares Worth $861,071, According to a Recent SEC Filing - marketscreener.com
UiPath (PATH) Is Up 36.6% After First GAAP Profit And Strong Q4 Outlook Has The Bull Case Changed? - Yahoo Finance
Better artificial intelligence stock: BigBear.ai vs. UiPath - MSN
Morgan Stanley Raises UiPath (PATH) Price Target to $19.00 | PAT - GuruFocus
UiPath Surges on Earnings: Should Investors Chase the Momentum? - MarketBeat
UiPath, Talkdesk Agree on Model Context Protocol-Based Agentic Integration - marketscreener.com
Better Artificial Intelligence Stock: BigBear.ai vs. UiPath - Finviz
UiPath and Talkdesk join forces to transform customer experience journeys - GlobeNewswire Inc.
Natixis Makes New Investment in UiPath, Inc. $PATH - MarketBeat
UiPath Inc reports record growth amidst challenges - MSN
Decoding UiPath Inc (PATH): A Strategic SWOT Insight - GuruFocus
UiPath (NYSE:PATH) Insider Brad Brubaker Sells 27,580 Shares of Stock - MarketBeat
UiPath (NYSE:PATH) Shares Up 3.2%Time to Buy? - MarketBeat
UiPath, Inc. SEC 10-Q Report - TradingView
Chmn Dines Sells 45,000 ($864.6K) Of UiPath Inc [PATH] - TradingView
Officer Brubaker Sells 27,580 ($511.7K) Of UiPath Inc [PATH] - TradingView
UiPath’s Remarkable Surge: Impact and Insights - timothysykes.com
UiPath (PATH) Stock Soars After First GAAP Profit: Can the AI Automation Rally Last? – December 8, 2025 - ts2.tech
UiPath, Inc. (PATH) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
UiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Spotting Winners: UiPath (NYSE:PATH) And Automation Software Stocks In Q3 - Finviz
Federated Hermes Inc. Boosts Position in UiPath, Inc. $PATH - MarketBeat
Why The Narrative Around UiPath Is Shifting Amid Cautious AI Optimism - Yahoo Finance
Scripting Automation Tools Market Is Going to Boom | UiPath • Automation Anywhere • Blue Prism - openPR.com
UiPath Shares Surge. Is It Too Late to Buy the Stock? - Nasdaq
Palantir Crushes 63% Growth While UiPath Celebrates Its First Profit - Yahoo Finance
Would You Still Hold UiPath Stock If It Fell 30%? - Trefis
UiPath outlines Q4 revenue target of up to $467M as agentic automation momentum accelerates - MSN
UiPath (PATH) Climbs 35% to New Record High on Stellar Q3 - Finviz
10 Stocks Sparking Massive Fortunes - Insider Monkey
UiPath (PATH) Price Target Increased by 15.84% to 15.99 - Nasdaq
UiPath (NYSE:PATH) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat
Insider Sell: Daniel Dines Sells 45,000 Shares of UiPath Inc (PA - GuruFocus
DA Davidson Maintains UiPath (PATH) Neutral Recommendation - Nasdaq
Officer Brubaker Files To Sell 27,580 Of UiPath Inc [PATH] - TradingView
Finanzdaten der Uipath Inc-Aktie (PATH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.79%
2.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):